June was a slower month on the pharma agency side, but were several hires worth reporting, as well as a couple of interesting appointments on the non-profit side.

Dozens of alumni of a group the State Department has linked to espionage have secured jobs in sensitive industries.

The rising occurrence of dysmenorrhea, along with greater awareness and advancements in diagnosis, is driving substantial growth in the dysmenorrhea ...

The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...

More than 30 years ago, when Jean-Pascal Tricoire first came to China, his friends gave him the Chinese ...

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global ...

Roche’s oral PI3K inhibitor Itovebi (inavolisib) has been approved by the European Commission (EC) as part of a combination ...

In a report released today, Justin Smith from Bernstein maintained a Buy rating on Sanofi, with a price target of €124.00. The company’s shares closed yesterday at $97.52. Take advantage of TipRanks ...

Epstein died by suicide in a jail cell in 2019 when he was awaiting trial on sex trafficking charges of underage girls. Even though Johnson blocked the vote on the files, several members of his own ...

Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...

The melanoma market is predicted to surge during the forecast period (2025–2034) owing to factors, as the increasing incidence of melanoma, the launc ...